Medical News Update
- FDA Actions to Support and Strengthen Domestic Drug Manufacturing
- C3TI Compass (Knowledge Repository)
- eCTD Submission Standards for eCTD v4.0 and Regional M1
- Patient Listening Session Summaries
- eCTD Submission Standards for eCTD v3.2.2 and Regional M1
- The FDA at 120: A Long, Distinguished History Protecting Americans
- What's New Related to Drugs
- Preparing Patient and Caregiver Participants for an FDA Patient-Led Listening Session and Suggested Topics
- Drug Repurposing: Considerations for Selection Criteria and Prioritization - 08/05/2026
- Learning and Education to ADvance and Empower Rare Disease Drug Developers (LEADER 3D)
- Generic Drug Facilities, Sites and Organization Lists
- PDUFA and BsUFA Quarterly Hiring Updates
- FDA Drug Competition Action Plan
- BsUFA IV: Fiscal Years 2028-2032
- National Drug Code Format
- Novel Drug Approvals for 2025
- Drug Trials Snapshots
- Drug Trials Snapshots: VOYXACT
- Phase 1 IND Guidance Documents
- Generic Drug User Fee Amendments